MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 18 filers reported holding MYRIAD GENETICS INC in Q1 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $212,000 | -22.9% | 6,939 | -5.5% | 0.02% | -15.8% |
| Q1 2016 | $275,000 | -41.6% | 7,339 | -32.7% | 0.02% | -50.0% |
| Q4 2015 | $471,000 | +0.9% | 10,904 | -12.4% | 0.04% | +2.7% |
| Q3 2015 | $467,000 | +10.4% | 12,450 | 0.0% | 0.04% | +27.6% |
| Q2 2015 | $423,000 | -2.8% | 12,450 | +1.3% | 0.03% | -3.3% |
| Q1 2015 | $435,000 | +2.6% | 12,294 | -1.3% | 0.03% | +3.4% |
| Q4 2014 | $424,000 | -11.7% | 12,450 | 0.0% | 0.03% | -17.1% |
| Q3 2014 | $480,000 | -23.2% | 12,450 | -22.4% | 0.04% | -16.7% |
| Q2 2014 | $625,000 | +13.8% | 16,050 | 0.0% | 0.04% | +20.0% |
| Q1 2014 | $549,000 | +37.2% | 16,050 | -15.9% | 0.04% | +29.6% |
| Q4 2013 | $400,000 | -1.0% | 19,080 | +11.1% | 0.03% | -22.9% |
| Q3 2013 | $404,000 | -15.1% | 17,180 | -3.1% | 0.04% | -28.6% |
| Q2 2013 | $476,000 | +7.4% | 17,730 | +1.7% | 0.05% | +4.3% |
| Q1 2013 | $443,000 | – | 17,440 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $98,875,000 | 3.47% |
| Tieton Capital Management, LLC | 187,636 | $3,711,000 | 2.72% |
| Glenview Capital Management | 3,682,691 | $72,825,000 | 1.67% |
| Altium Capital Management LP | 218,650 | $4,324,000 | 1.61% |
| S&T BANK/PA | 331,098 | $6,547,000 | 1.18% |
| EARNEST PARTNERS LLC | 6,731,429 | $133,114,000 | 0.92% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,078,075 | $41,094,000 | 0.79% |
| SummerHaven Investment Management, LLC | 35,700 | $706,000 | 0.55% |
| AIMZ Investment Advisors, LLC | 42,685 | $844,000 | 0.44% |
| CONTINENTAL ADVISORS LLC | 36,392 | $720,000 | 0.33% |